Glenmede Trust Company »

Vertex Pharmaceuticals Incorporated shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2012-12-31 $35k 837 41.82
2012-09-30 $46k 837 54.96
2012-06-30 $57k 1.0k 54.78
2012-03-31 $44k 1.1k 40.20
2011-12-31 $35k 1.1k 31.83
2010-12-31 $63k 1.8k 34.50

More positions owned by Glenmede Trust Company

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Oracle Corporation (ORCL)
Home Depot (HD)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Small Cp Etf (VB)
Procter & Gamble Company (PG)

View all positions for Glenmede Trust Company

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated